BPC-157 for Inflammation: Benefits, Research, and Recovery Support One reason BPC-157 has become so popular is its potential versatility
CJC-1295 and Ipamorelin increase GH output and IGF-1 levels, while BPC-157 accelerates structural healing
In Russia, Semax has been: Approved as a pharmaceutical since 2011 Prescribed for ischemic stroke (acute and recovery phases) Used for cognitive disorders, including memory impairment and attention deficits Administered as a nasal spray, making it convenient and non-invasive Studied extensively, with hundreds of published scientific papers Given to healthy individuals for cognitive optimization (a practice common among Russian military and high-performance professionals) This decades-long track record of clinical use with a robust safety profile documented in Russian medical literature is one of the strongest arguments for Semax's inclusion on the US 503A compounding list
The advanced autoantibody panel, Neural Zoomer Plus , screens for immune reactivity to key neural targets, including myelin basic protein, NMDA receptors, gangliosides, synapsin, S100B, and blood-brain barrier proteins
